pre-IPO PHARMA

COMPANY OVERVIEW

Singh Biotechnology (SBT) is a start-up biotech organization established in 2014 which discovers and develops unique and proprietary therapeutic single domain antibodies (sdAbs) for the treatment of a variety of cancers, autoimmune and ophthalmic diseases by leveraging its novel technology platform.


LOCATION

  • Tampa, FL, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.singhbiotechnology.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    For More Press Releases


    Google Analytics Alternative